Esquire Financial (ESQ) CEO receives 8,148-share restricted stock grant

Rhea-AI Filing Summary

Esquire Financial Holdings Vice Chairman, President & CEO Andrew C. Sagliocca received an award of 8,148 shares of common stock on January 29, 2026. The shares were granted at $0 per share as restricted stock, a common form of equity compensation.

These restricted shares vest in three equal annual installments beginning on January 29, 2029298,798 shares directly, which include several prior restricted stock awards scheduled to vest in three annual installments starting on December 16, 2024; December 9, 2025; December 19, 2026; December 15, 2027; and January 30, 2028.

02/02/2026 - 12:20 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sagliocca Andrew C

(Last) (First) (Middle)

100 JERICHO QUADRANGLE

SUITE 100

(Street)

JERICHO NY 11753

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Esquire Financial Holdings, Inc. [ ESQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice Chairman, President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/29/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/29/2026		A		8,148(1)	A	$0	298,798(2)(3)(4)(5)(6)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares of restricted stock vest in three equal annual installments commencing on January 29, 2029.

2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.

3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.

4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.

5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.

6. Includes shares of restricted stock which vest in three equal annual installments commencing on January 30, 2028.

	/s/ Eric S. Bader, pursuant to power of attorney	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Esquire Financial (ESQ) disclose about insider equity awards?

Esquire Financial reported that its Vice Chairman, President & CEO Andrew C. Sagliocca received 8,148 shares of restricted common stock at $0 per share. These shares vest over time, adding to his long-term equity-based compensation and aligning interests with other shareholders.

How many Esquire Financial (ESQ) shares does Andrew C. Sagliocca now beneficially own?

Following the latest restricted stock grant, Andrew C. Sagliocca beneficially owns 298,798 shares of Esquire Financial common stock. This total includes multiple restricted stock awards that vest in scheduled annual installments over several years, subject to the stated vesting conditions.

When do the new Esquire Financial (ESQ) restricted shares granted to the CEO vest?

The 8,148 newly granted restricted shares to CEO Andrew C. Sagliocca vest in three equal annual installments starting January 29, 2029. This multi‑year vesting schedule is designed to extend his equity exposure and encourage longer-term alignment with company performance.

What other Esquire Financial (ESQ) restricted stock grants are outstanding for the CEO?

In addition to the January 29, 2026 grant, Sagliocca holds restricted shares that vest in three equal annual installments beginning on December 16, 2024; December 9, 2025; December 19, 2026; December 15, 2027; and January 30, 2028, as disclosed.

Is the latest Esquire Financial (ESQ) insider transaction a purchase or an award?

The filing shows an award of 8,148 shares of Esquire Financial common stock to Andrew C. Sagliocca coded as an acquisition at $0 per share. This indicates an equity compensation grant, not an open-market purchase by the executive.

What is Andrew C. Sagliocca’s role at Esquire Financial (ESQ)?

Andrew C. Sagliocca is identified as a Director and as an Officer of Esquire Financial, serving as Vice Chairman, President & CEO. His equity awards and share ownership reflect his leadership position and long-term involvement with the company.